No Arbitration of Patent/Confidentiality Issues. Unless otherwise agreed by the Parties, disputes relating to Patents and non-disclosure, non-use and maintenance of Confidential Information shall not be subject to arbitration, and shall be submitted to a court of competent jurisdiction.
Appears in 5 contracts
Samples: Research and Development Option and License Agreement (Anacor Pharmaceuticals Inc), Research and Development Collaboration, Option and License Agreement (Anacor Pharmaceuticals Inc), Research and Development Collaboration, Option and License Agreement (Anacor Pharmaceuticals Inc)
No Arbitration of Patent/Confidentiality Issues. Unless otherwise agreed by the Parties, disputes relating to Patents patents and non-disclosure, non-use and maintenance of Confidential Information shall not be subject to arbitration, and shall be submitted to a court of competent jurisdiction.
Appears in 4 contracts
Samples: License, Development, and Commercialization Agreement (Novacea Inc), And Commercialization Agreement (Anacor Pharmaceuticals Inc), Hspe7 Collaboration Agreement (Stressgen Biotechnologies Corp)
No Arbitration of Patent/Confidentiality Issues. Unless otherwise agreed by the Parties, disputes relating to Patents and or non-disclosure, non-use and or maintenance of Confidential Information shall not be subject to arbitration, and shall be submitted to a court of competent jurisdiction.
Appears in 3 contracts
Samples: License Agreement (Aptalis Pharma Inc), Development Agreement (Aptalis Pharma Inc), Option Agreement (Aptalis Pharma Inc)
No Arbitration of Patent/Confidentiality Issues. Unless otherwise agreed by the Parties, disputes to the extent relating to Patents and Know-How and non-disclosure, non-use and maintenance of Confidential Information shall not be subject to arbitration, and shall be submitted to a court of competent jurisdiction.
Appears in 2 contracts
Samples: Exclusive License Agreement (Rexahn Pharmaceuticals, Inc.), Exclusive License Agreement (EyePoint Pharmaceuticals, Inc.)
No Arbitration of Patent/Confidentiality Issues. Unless otherwise agreed by the Parties, disputes relating to Patents and Know-How and non-disclosure, non-use and maintenance of Confidential Information shall not be subject to arbitration, and shall be submitted to a court of competent jurisdiction. For the sake of clarity, all discussions and any exchange of documents, written consultations or opinions relating to a dispute or the arbitration procedures set forth in this Section 13.2, shall be considered as a Confidential Information.
Appears in 1 contract
Samples: Collaboration and License Agreement (Rexahn Pharmaceuticals, Inc.)
No Arbitration of Patent/Confidentiality Issues. Unless otherwise agreed by the Parties, disputes relating to Patents patents and non-disclosure, non-use and maintenance of Confidential Information shall not be subject to arbitration, and shall be submitted to a court of competent jurisdiction. In addition, either Party may seek preliminary or injunctive relief and/or other equitable relief in any court of competent jurisdiction.
Appears in 1 contract
Samples: Diagnostic Collaboration and Option Agreement (ARCA Biopharma, Inc.)
